<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37724290</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>20</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2235-2988</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in cellular and infection microbiology</Title><ISOAbbreviation>Front Cell Infect Microbiol</ISOAbbreviation></Journal><ArticleTitle>Coinfection of SARS-CoV-2 and influenza A (H3N2) detected in bronchoalveolar lavage fluid of a patient with long COVID using metagenomic next-generation sequencing: a case report.</ArticleTitle><Pagination><StartPage>1224794</StartPage><MedlinePgn>1224794</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1224794</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fcimb.2023.1224794</ELocationID><Abstract><AbstractText>The growing number of long COVID cases has drawn clinical attention to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has been spreading worldwide since winter 2019. Its symptoms are not limited to fatigue and shortness of breath but also affect daily life. We report the use of metagenomic next-generation sequencing (mNGS) to detect coinfection with SARS-CoV-2 and influenza A virus in a patient with long COVID. The patient was admitted with fever, expectoration, fatigue, and shortness of breath. The PCR test was negative due to possible clearance of SARS-Cov-2 in the upper respiratory tract of patients with long COVID. Other routine microbiological tests were also negative, making the clinical diagnosis difficult. Bronchoalveolar lavage fluid (BALF) samples were tested using mNGS. The patient was diagnosed and treated promptly, recovered quickly, and continued taking azvudine after discharge; his condition was stable. This study illustrates that mNGS may be valuable for the timely diagnosis of patients with long COVID and their mixed infections.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Liang, Wang, Liu, Ma, Zhang, Wang, Yu and Wang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Xuefei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Sinopharm North Hospital, Baotou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qiushi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Infection Business Unit, Tianjin Novogene Med LAB Co., Ltd., Tianjin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infection Business Unit, Novogene Co., Ltd., Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Infection Business Unit, Tianjin Novogene Med LAB Co., Ltd., Tianjin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infection Business Unit, Novogene Co., Ltd., Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Sinopharm North Hospital, Baotou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yajuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Sinopharm North Hospital, Baotou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Infection Business Unit, Tianjin Novogene Med LAB Co., Ltd., Tianjin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infection Business Unit, Novogene Co., Ltd., Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Infection Business Unit, Tianjin Novogene Med LAB Co., Ltd., Tianjin, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infection Business Unit, Novogene Co., Ltd., Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Linlin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, Sinopharm North Hospital, Baotou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Cell Infect Microbiol</MedlineTA><NlmUniqueID>101585359</NlmUniqueID><ISSNLinking>2235-2988</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053122" MajorTopicYN="N">Influenza A Virus, H3N2 Subtype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001992" MajorTopicYN="N">Bronchoalveolar Lavage Fluid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004417" MajorTopicYN="N">Dyspnea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">BALF</Keyword><Keyword MajorTopicYN="N">Coinfection</Keyword><Keyword MajorTopicYN="N">H3N2</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">diagnose</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">metagenomic next-generation sequencing</Keyword></KeywordList><CoiStatement>QW, JL, MW, and YY are employed by Novogene Co., Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>19</Day><Hour>3</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37724290</ArticleId><ArticleId IdType="pmc">PMC10505437</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2023.1224794</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abdelrahman Z., Li M., Wang X. (2020). Comparative review of SARS-CoV-2, SARS-coV, MERS-coV, and influenza A respiratory viruses. Front. Immunol. 11. doi:&#xa0;10.3389/fimmu.2020.552909</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.552909</ArticleId><ArticleId IdType="pmc">PMC7516028</ArticleId><ArticleId IdType="pubmed">33013925</ArticleId></ArticleIdList></Reference><Reference><Citation>Biamonte F., Botta C., Mazzitelli M., Rotundo S., Trecarichi E. M., Foti D., et al. . (2021). Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility. J. Transl. Med. 19, 79. doi:&#xa0;10.1186/s12967-021-02744-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02744-2</ArticleId><ArticleId IdType="pmc">PMC7887565</ArticleId><ArticleId IdType="pubmed">33596963</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Cox R. J., Langeland N. (2022). Long COVID: A growing problem in need of intervention. Cell Rep. Med. 3, 100552. doi:&#xa0;10.1016/j.xcrm.2022.100552</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100552</ArticleId><ArticleId IdType="pmc">PMC8841141</ArticleId><ArticleId IdType="pubmed">35474749</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussani R., Zentilin L., Correa R., Colliva A., Silvestri F., Zacchigna S., et al. . (2023). Persistent SARS-CoV-2 infection in patients seemingly recovered from COVID-19. J. Pathol. 259, 254&#x2013;263. doi:&#xa0;10.1002/path.6035</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.6035</ArticleId><ArticleId IdType="pmc">PMC10107739</ArticleId><ArticleId IdType="pubmed">36651103</ArticleId></ArticleIdList></Reference><Reference><Citation>Chee Y. J., Fan B. E., Young B. E., Dalan R., Lye D. C. (2023). Clinical trials on the pharmacological treatment of long COVID: A systematic review. J. Med. Virol. 95, e28289. doi:&#xa0;10.1002/jmv.28289</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28289</ArticleId><ArticleId IdType="pmc">PMC9878018</ArticleId><ArticleId IdType="pubmed">36349400</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Kang Y., Li D., Li Z. (2022). Diagnostic performance of metagenomic next-generation sequencing for the detection of pathogens in bronchoalveolar lavage fluid in patients with pulmonary infections: Systematic review and meta-analysis. Int. J. Infect. Dis. 122, 867&#x2013;873. doi:&#xa0;10.1016/j.ijid.2022.07.054</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.07.054</ArticleId><ArticleId IdType="pubmed">35907477</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Zhang R., Liu L., Qi T., Wang Z., Song W., et al. . (2021). Clinical usefulness of metagenomic next-generation sequencing for the diagnosis of central nervous system infection in people living with HIV. Int. J. Infect. Dis. 107, 139&#x2013;144. doi:&#xa0;10.1016/j.ijid.2021.04.057</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.04.057</ArticleId><ArticleId IdType="pubmed">33892189</ArticleId></ArticleIdList></Reference><Reference><Citation>Domen J., Tans A., Janssens S., Wickramasinghe D., Lannoy V., Horn S. R. A., et al. . (2022). Cochrane COVID-19 Diagnostic Test Accuracy Group. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Cochrane Database Syst. Rev. 5, CD013665. doi:&#xa0;10.1002/14651858.CD013665.pub3</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD013665.pub3</ArticleId><ArticleId IdType="pmc">PMC9121352</ArticleId><ArticleId IdType="pubmed">35593186</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahim M., Ghonim H. A. E. S., Roshdy W. H., Naguib A., Elguindy N., AbdelFatah M., et al. . (2021). Coinfection with SARS-CoV-2 and influenza A(H1N1) in a patient seen at an influenza-like illness surveillance site in Egypt: case report. JMIR Public Health Surveill. 28, 7,e27433. doi:&#xa0;10.2196/27433</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/27433</ArticleId><ArticleId IdType="pmc">PMC8081026</ArticleId><ArticleId IdType="pubmed">33784634</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang L., Liang X. (2022). ISW-LM: An intensive symptom weight learning mechanism for early COVID-19 diagnosis. Comput. Biol. Med. 146, 105615. doi:&#xa0;10.1016/j.compbiomed.2022.105615</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2022.105615</ArticleId><ArticleId IdType="pmc">PMC9112616</ArticleId><ArticleId IdType="pubmed">35605484</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman E. L., Savelieff M. G., Hayek S. S., Pennathur S., Kretzler M., Pop-Busui R. (2020). COVID-19 and diabetes: A collision and collusion of two diseases. Diabetes 69, 2549&#x2013;2565. doi:&#xa0;10.2337/dbi20-0032</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dbi20-0032</ArticleId><ArticleId IdType="pmc">PMC7679769</ArticleId><ArticleId IdType="pubmed">32938731</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C. (2022). Long COVID: current definition. Infection 50, 285&#x2013;286. doi:&#xa0;10.1007/s15010-021-01696-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01696-5</ArticleId><ArticleId IdType="pmc">PMC8438555</ArticleId><ArticleId IdType="pubmed">34519974</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y. D., Ding M., Dong X., Zhang J. J., Kursat Azkur A., Azkur D., et al. . (2021). Risk factors for severe and critically ill COVID-19 patients: A review. Allergy 76, 428&#x2013;455. doi:&#xa0;10.1111/all.14657</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14657</ArticleId><ArticleId IdType="pubmed">33185910</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., et al. . (2021). 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet 397, 220&#x2013;232. doi:&#xa0;10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E. H., Nguyen T. Q., Casel M. A. B., Rollon R., Kim S. M., Kim Y. I., et al. . (2022). Coinfection with SARS-CoV-2 and influenza A virus increases disease severity and impairs neutralizing antibody and CD4+ T cell responses. J. Virol. 96, e0187321. doi:&#xa0;10.1128/jvi.01873-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01873-21</ArticleId><ArticleId IdType="pmc">PMC8941868</ArticleId><ArticleId IdType="pubmed">35107382</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari R., Sharma S. D., Kumar A., Ende Z., Mishina M., Wang Y., et al. . (2023). Antiviral approaches against influenza virus. Clin. Microbiol. Rev. 36, e0004022. doi:&#xa0;10.1128/cmr.00040-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/cmr.00040-22</ArticleId><ArticleId IdType="pmc">PMC10035319</ArticleId><ArticleId IdType="pubmed">36645300</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling Y., Xu S. B., Lin Y. X., Tian D., Zhu Z. Q., Dai F. H., et al. . (2020). Persistence and clearance of viral RNA in 2019 novel coronavirus disease rehabilitation patients. Chin Med J (Engl), 133 1039&#x2013;1043. doi:&#xa0;10.1097/CM9.0000000000000774</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000000774</ArticleId><ArticleId IdType="pmc">PMC7147278</ArticleId><ArticleId IdType="pubmed">32118639</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Zhang Q., Dong Y. Q., Yin J., Qiu Y. Q. (2022). Diagnostic accuracy of metagenomic next-generation sequencing in diagnosing infectious diseases: a meta-analysis. Sci. Rep. 5, 12,21032. doi:&#xa0;10.1038/s41598-022-25314-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-25314-y</ArticleId><ArticleId IdType="pmc">PMC9723114</ArticleId><ArticleId IdType="pubmed">36470909</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S., Zhang F., Zhou F., Li H., Ge W., Gan R., et al. . (2021). Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19. Signal Transduct Target Ther. 6, 191. doi:&#xa0;10.1038/s41392-021-00614-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00614-3</ArticleId><ArticleId IdType="pmc">PMC8116522</ArticleId><ArticleId IdType="pubmed">33986253</ArticleId></ArticleIdList></Reference><Reference><Citation>Mina S., Yaakoub H., Annweiler C., Dub&#xe9;e V., Papon N. (2022). COVID-19 and Fungal infections: a double debacle. Microbes Infect. 24, 105039. doi:&#xa0;10.1016/j.micinf.2022.105039</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2022.105039</ArticleId><ArticleId IdType="pmc">PMC9400371</ArticleId><ArticleId IdType="pubmed">36030024</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson E. G., Avadhanula V., Fragoso S., Stroh R., Ye X., Bond N., et al. . (2021). SARS-CoV-2 re-infection versus prolonged shedding: A case series. Influenza Other Respir. Viruses. 15, 691&#x2013;696. doi:&#xa0;10.1111/irv.12879</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12879</ArticleId><ArticleId IdType="pmc">PMC8242882</ArticleId><ArticleId IdType="pubmed">34085762</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z., Wang H., Cui G., Lu H., Wang L., Luo H., et al. . (2021). Alterations in the human oral and gut microbiomes and lipidomics in COVID-19. Gut 70, 1253&#x2013;1265. doi:&#xa0;10.1136/gutjnl-2020-323826</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323826</ArticleId><ArticleId IdType="pmc">PMC8042598</ArticleId><ArticleId IdType="pubmed">33789966</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J. B., Murthy S., Marshall J. C., Relan P., Diaz J. V. (2022). WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 22, e102&#x2013;e107. doi:&#xa0;10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreenath K., Batra P., Vinayaraj E. V., Bhatia R., SaiKIran K., Singh V., et al. . (2021). Coinfections with other respiratory pathogens among patients with COVID-19. Microbiol. Spectr. 9, e0016321. doi:&#xa0;10.1128/Spectrum.00163-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/Spectrum.00163-21</ArticleId><ArticleId IdType="pmc">PMC8552727</ArticleId><ArticleId IdType="pubmed">34287033</ArticleId></ArticleIdList></Reference><Reference><Citation>Swets M. C., Russell C. D., Harrison E. M., Docherty A. B., Lone N., Girvan M., et al. . (2022). SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses. Lancet 399, 1463&#x2013;1464. doi:&#xa0;10.1016/S0140-6736(22)00383-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00383-X</ArticleId><ArticleId IdType="pmc">PMC8956294</ArticleId><ArticleId IdType="pubmed">35344735</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Huang K., Jiang H., Hua L., Yu W., Ding D., et al. . (2020). Long-term existence of SARS-CoV-2 in COVID-19 patients: host immunity, viral virulence, and transmissibility. Virol. Sin. 35, 793&#x2013;802. doi:&#xa0;10.1007/s12250-020-00308-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12250-020-00308-0</ArticleId><ArticleId IdType="pmc">PMC7644793</ArticleId><ArticleId IdType="pubmed">33156486</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanhella K. J., Fernandez-Patron C. (2022). Biomarkers of ageing and frailty may predict COVID-19 severity. Ageing Res. Rev. 73, 101513. doi:&#xa0;10.1016/j.arr.2021.101513</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arr.2021.101513</ArticleId><ArticleId IdType="pmc">PMC8611822</ArticleId><ArticleId IdType="pubmed">34838734</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiech M., Chroscicki P., Swatler J., Stepnik D., Biasi S., Hampel M., et al. . (2022). Remodeling of T cell dynamics during long COVID is dependent on severity of SARS-coV-2 infection. Front. Immunol. 13. doi:&#xa0;10.3389/fimmu.2022.886431</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.886431</ArticleId><ArticleId IdType="pmc">PMC9226563</ArticleId><ArticleId IdType="pubmed">35757700</ArticleId></ArticleIdList></Reference><Reference><Citation>Wikramaratna P. S., Paton R. S., Ghafari M., Louren&#xe7;o J. (2020). Estimating the false-negative test probability of SARS-CoV-2 by RT-PCR. Euro Surveill. 25, 2000568. doi:&#xa0;10.2807/1560-7917.ES.2020.25.50.2000568</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.50.2000568</ArticleId><ArticleId IdType="pmc">PMC7812420</ArticleId><ArticleId IdType="pubmed">33334398</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Cai Y., Huang X., Yu X., Zhao L., Wang F., et al. . (2020). Co-infection with SARS-CoV-2 and influenza A virus in patient with pneumonia, China. Emerg. Infect. Dis. 26, 1324&#x2013;1326. doi:&#xa0;10.3201/eid2606.200299</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2606.200299</ArticleId><ArticleId IdType="pmc">PMC7258479</ArticleId><ArticleId IdType="pubmed">32160148</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Y., Jiao B., Qu L., Yang D., Liu R. (2023). The development of COVID-19 treatment. Front. Immunol. 14. doi:&#xa0;10.3389/fimmu.2023.1125246</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1125246</ArticleId><ArticleId IdType="pmc">PMC9909293</ArticleId><ArticleId IdType="pubmed">36776881</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y. M., Shang Y. M., Song W. B., Li Q. Q., Xie H., Xu Q. F., et al. . (2020). Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine 25, 100463. doi:&#xa0;10.1016/j.eclinm.2020.100463</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100463</ArticleId><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Chi J., Lv W., Wang Y. (2021). Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19). Diabetes Metab. Res. Rev. 37, e3377. doi:&#xa0;10.1002/dmrr.3377</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/dmrr.3377</ArticleId><ArticleId IdType="pmc">PMC7361201</ArticleId><ArticleId IdType="pubmed">32588943</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>